Inovio Pharmaceuticals, Inc. · NASDAQ:INO

Shea Jacqueline Elizabeth exercised options for 28,296 Inovio Pharmaceuticals, Inc. shares (Form 4)

Traded May 20, 2026 · Filed May 21, 2026

On May 20, 2026, Shea Jacqueline Elizabeth (Director, Chief Executive Officer) exercised options for 28,296 Inovio Pharmaceuticals, Inc. shares, leaving 111,021 shares. Filed May 21, 2026 (Form 4).

Options exercised
28,296 shares
Holding after
111,021 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockOption exercise28,296123,327Direct
May 20, 2026Common StockShares withheld for tax12,306US$1.23111,021Direct

Source

View original at SEC

Related